|
KMID : 1143120210110020017
|
|
Asia Pacific Allergy
2021 Volume.11 No. 2 p.17 ~ p.17
|
|
|
A case of bortezomib (Velcade)?induced Stevens-Johnson syndrome confirmed by patch test
|
|
Choi Gil-Soon
Lee Ho-Sup
Kim Hee-Kyoo
|
|
|
Abstract
|
|
|
|
Bortezomib, a highly selective reversible inhibitor of the proteasome complex, is used to the current standard of care in the treatment of multiple myeloma. Although its most commonly reported side effects are gastrointestinal symptoms, peripheral neuropathy, neuropathic pain, and thrombocytopenia, cutaneous adverse reactions are also frequently seen. However, severe cutaneous adverse reactions (SCAR) such as Stevens-Johnson syndrome (SJS) occur very rarely. Here we report the first case of bortezomib-induced SJS with confirmed by patch test. In this case, we performed a patch test that proved bortezomib was the offensive drug in this patient, who had been treated with multiple drugs including antibiotics, allopurinol, and anticancer drugs. Although bortezomib-induced SCARs are generally very rare, we suggest that clinicians be aware of potential adverse reactions including SJS.
|
|
|
KEYWORD
|
|
|
Bortezomib, Stevens-Johnson syndrome, Drug hypersensitivity, Drug eruptions
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|